<DOC>
	<DOCNO>NCT00746096</DOCNO>
	<brief_summary>The purpose study determine whether combination oral contraceptive pill norethindrone ethinyl estradiol effective treatment primary dysmenorrhea .</brief_summary>
	<brief_title>Efficacy Safety Study Low Dose Oral Contraceptive Pill Treat Primary Dysmenorrhea</brief_title>
	<detailed_description />
	<mesh_term>Dysmenorrhea</mesh_term>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Contraceptives , Oral</mesh_term>
	<mesh_term>Norethindrone</mesh_term>
	<mesh_term>Norethindrone acetate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Anti-Inflammatory Agents , Non-Steroidal</mesh_term>
	<mesh_term>Contraceptives , Oral , Combined</mesh_term>
	<criteria>primary dysmenorrhea severe hepatopathy pregnant woman</criteria>
	<gender>Female</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>